The presence of recurrent delCT mutations was investigated by high-sensitivity polymerase chain reaction (PCR)-based methods (i.e., allele-specific and droplet digital PCR) to identify the NOTCH1 mutant in up to half of CLL patients (66–68). The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.